Integrating a New Treatment Option Into the Armamentarium for ER+ / HER2- Metastatic Breast Cancer

Randy Scott from Pfizer has been gracious enough to sponsor Charina Toste, NP from the Cancer and Blood Specialists of Nevada to speak to us about integrating a new treatment option into the armamentarium for ER+/HER2- metastatic breast cancer. This dinner will be hosted at Opus Prime at 1800. Registration can be completed at and the meeting ID is EZ25564682. Additional program information can be found in the attached invitation.

Click Here for more information

No comments have been posted yet.